Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celix Pharma is a pharmaceutical company headquartered in London, United Kingdom, specializing in the development and commercialization of generic and value-added medicines. The company operates an asset-light business model, focusing its internal resources on research and development, regulatory strategy, and portfolio management while outsourcing manufacturing to strategic partners. Celix Pharma targets a diverse range of therapeutic areas, including the central nervous system, cardiovascular health, and anti-infectives. With a growing presence in the UK and European markets, the firm aims to provide cost-effective healthcare solutions through a robust pipeline of niche and complex generic products. The leadership team brings extensive experience from global pharmaceutical organizations to drive the company's expansion and market penetration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celix Pharma.